Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study

por Paez, Isis, Prado, Yalena, Ubilla, Carmen G., Zambrano, Tomás, Salazar, Luis A.
Publicado 2020

SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals

por Prado, Yalena, Saavedra, Nicolás, Zambrano, Tomás, Lagos, Jenny, Rosales, Alexy, Salazar, Luis A.
Publicado 2015

Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study

por Paez, Isis, Prado, Yalena, Loren, Pía, Ubilla, Carmen G., Rodríguez, Nelia, Salazar, Luis A.
Publicado 2023

MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy

por Saavedra, Kathleen, Leal, Karla, Saavedra, Nicolás, Prado, Yalena, Paez, Isis, Ubilla, Carmen G., Rojas, Gabriel, Salazar, Luis A.
Publicado 2022

CYP2C19(⁎)2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

por Ruedlinger, Jenny, Prado, Yalena, Zambrano, Tomás, Saavedra, Nicolás, Bobadilla, Braulio, Potthoff, Marcelo, Pérez, Luis, Lanas, Fernando, Salazar, Luis A.
Publicado 2017

MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study

por Ubilla, Carmen Gloria, Prado, Yalena, Angulo, Jeremy, Obreque, Ignacio, Paez, Isis, Saavedra, Nicolás, Saavedra, Kathleen, Zambrano, Tomás, Salazar, Luis A.
Publicado 2021